DALLAS, March 29, 2005 (PRIMEZONE) -- TalkingStocks.com has issued an updated Profile report on Biophan Technologies (OTCBB:BIPH). The report is authored by Senior Analyst, Shailesh Dhuri, CFA. In the report, Mr. Dhuri writes, "Biophan is an emerging biomedical device company that seeks to meet an urgent need to make biomedical devices MRI-compatible. The company develops enabling technologies for safe and effective imaging under MRI of implanted medical systems such as pacemakers, interventional surgical devices such as catheters and guidewires, as well as stents and other implants."
Mr. Dhuri goes on to write about the Company's other patent award related to a Vena Cava filter, and an application for the development of a revolutionary ceramic-based motor. The report concludes with an updated outlook both for the Company and its products.
To view the report, please visit:
http://talkingstocks.com/reports/BIPH_032905.php
Registration is free.
About TalkingStocks.com
StockGuru.com and TalkingStocks.com are two of the leading destinations on the internet for information on small and micro cap companies. Companies interested in our services may contact our Publisher, John Pentony, to discuss featuring a company on our web sites. To contact our Publisher, either telephone: (972) 731-8621 or email john@talkingstocks.com.
Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement Under the Private Securities Litigation Act of 1995 -- With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of TEQI could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rate and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors see the risk factors associated with our Company, review our SEC filings.
Disclosure: As of the date of this release, TalkingStocks.com, LLC, and its affiliate Pentony Enterprises, LLC (StockGuru.com), have been compensated an aggregate total of $24,000 for continuing coverage. The company paid $18,000 for coverage. Prior compensation of $6,000 came from Trilogy Capital Partners, the investor relations firm for Biophan Technologies (BIPH). Neither TalkingStocks.com, LLC, nor Pentony Enterprises, LLC, are registered investment advisers or broker/dealers. TalkingStocks.com, LLC and Pentony Enterprises, LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.